Pfizer's Arena goal? Get out of the way and don't 'break the new toy'
Pfizer's Arena goal? Get out of the way and don't 'break the new toy'
aarmstrong
Thu, 05/19/2022 - 15:44
Chutes & Ladders—Aquestive CEO heads for the exits while seizure med remains in regulatory limbo
Chutes & Ladders—Aquestive CEO heads for the exits while seizure med remains in regulatory limbo
mbayer
Thu, 05/19/2022 - 15:21
Calling all Fierce 15 fans: Nominations for the 2022 Fierce Biotech Fierce 15 are now open
Calling all Fierce 15 fans: Nominations for the 2022 Fierce Biotech Fierce 15 are now open
aarmstrong
Thu, 05/19/2022 - 12:59
FDA clears NeuroMetrix’s wearable neuromodulator as first non-drug fibromyalgia treatment
FDA clears NeuroMetrix’s wearable neuromodulator as first non-drug fibromyalgia treatment
apark
Thu, 05/19/2022 - 11:59
XACT's needle-guiding robot scores FDA clearance for ablation procedures
XACT's needle-guiding robot scores FDA clearance for ablation procedures
chale
Thu, 05/19/2022 - 11:11
Pfizer teams up with Headlands Research to launch trial sites in more diverse areas
Pfizer teams up with Headlands Research to launch trial sites in more diverse areas
gmasson
Thu, 05/19/2022 - 10:38
Brain-computer interface zooms ahead in helping paralysis patient drive again
Brain-computer interface zooms ahead in helping paralysis patient drive again
apark
Thu, 05/19/2022 - 10:13
Inceptor Bio to use $37M series A to nudge CAR-T toward clinic, establish manufacturing base
Inceptor Bio to use $37M series A to nudge CAR-T toward clinic, establish manufacturing base
jwaldron
Thu, 05/19/2022 - 09:40
Compliance in at-home studies comparable to site-based trials: study
Compliance in at-home studies comparable to site-based trials: study
aarmstrong
Thu, 05/19/2022 - 09:01
Amgen celebrates 25 years of deCODE Genetics as partnership evolves from discovery to development
Amgen celebrates 25 years of deCODE Genetics as partnership evolves from discovery to development
mbayer
Thu, 05/19/2022 - 08:48
Enanta sinks to multiyear low as phase 2b RSV trial flames out
Enanta sinks to multiyear low as phase 2b RSV trial flames out
ntaylor
Thu, 05/19/2022 - 06:45
Nanobiotix scales down R&D plan, freezes hiring to close gap between cash runway and phase 3 data
Nanobiotix scales down R&D plan, freezes hiring to close gap between cash runway and phase 3 data
ntaylor
Thu, 05/19/2022 - 05:52
Merck to pay up to $1.4B in cancer deal with Kelun, but details are scarce
Merck to pay up to $1.4B in cancer deal with Kelun, but details are scarce
mbayer
Wed, 05/18/2022 - 15:26
J&J-backed Locus closes $35M financing to push CRISPR-based antibacterial drug into phase 2/3
J&J-backed Locus closes $35M financing to push CRISPR-based antibacterial drug into phase 2/3
gmasson
Wed, 05/18/2022 - 15:08
C2N launches tau-tallying Alzheimer's blood test to join its amyloid-based screening tool
C2N launches tau-tallying Alzheimer's blood test to join its amyloid-based screening tool
apark
Wed, 05/18/2022 - 12:21
Applied Molecular Transport’s co-founder exits along with 40% of staff as early pipeline activity paused
Applied Molecular Transport’s co-founder exits along with 40% of staff as early pipeline activity paused
gmasson
Wed, 05/18/2022 - 11:11
How Amgen and AstraZeneca's asthma drug Tezspire holds promise for colorectal cancer
How Amgen and AstraZeneca's asthma drug Tezspire holds promise for colorectal cancer
aliu
Wed, 05/18/2022 - 11:05
J&J’s DePuy Synthes scores FDA clearance in reverse shoulder joint replacements
J&J’s DePuy Synthes scores FDA clearance in reverse shoulder joint replacements
chale
Wed, 05/18/2022 - 10:42
Reaction Biology bolsters executive team with new commercial, HR heads
Reaction Biology bolsters executive team with new commercial, HR heads
aarmstrong
Wed, 05/18/2022 - 10:33
'We just don’t have the studies': New report details critical diversity shortcomings in US clinical research
'We just don’t have the studies': New report details critical diversity shortcomings in US clinical research
aarmstrong
Wed, 05/18/2022 - 10:08